Compounded Tirzepatide, Compared on Price and Pharmacy Transparency
6 providers, each read directly off its own site — 3 quote a floor price with no breakdown of what a real dose costs; only 2 names its pharmacy and states a regulatory category.
/ The board
Any paid placement on this board is marked Partner and printed as a disclosed commercial position — every row here is ranked on the criteria printed on this page (see disclosure). Full write-ups below.
“Flat price” means one all-in monthly figure with no separate membership or lab fee; any other pricing chip names the mechanic that gets in the way, or that the provider has not stated one. “Labs” is whether bloodwork is required, optional, not used, or not stated on the provider's own site. The pharmacy chip states a facility type (503A pharmacy, 503B facility) only where the provider publishes one we could cite; “Not disclosed” means we read their site and they do not say, and “Unverified” means nobody has checked this company's pharmacy sourcing yet — of the 6 providers on this board, 2 publish a facility type at all. Every provider here includes the clinician consult. Prices were verified on each provider's own site in 2026 and can change without notice.
Top-ranked on our criteria
$99/mo+
1
Found
One of only two providers on this board whose own site states a regulatory category for its pharmacy — and the one with the lowest headline price, though that $99/mo figure is published for its whole compounded-GLP-1 category, not confirmed as tirzepatide's own number, and assumes paying for multiple months up front.
FO
Found's own homepage FAQ advertises "compounded GLP-1s starting at $99/month (with flat pricing as your dose increases)." Its dedicated compounded-tirzepatide page shows its actual price only inside an interactive comparison graphic our text-only site check could not read, so we could not independently confirm $99 is tirzepatide's own figure. The same product page states, "Pricing reflects cash pay on a multi-month plan; see offer terms," and Found's own FAQ adds, "Longer plans at 3, 6, and 12 months keep your monthly cost down" — so the number that is published assumes prepaying for more than one month.
Found's compounded-tirzepatide page carries the more direct of the two regulatory-category disclosures on this board — it states, in its own words, "Found partners exclusively with licensed 503A compounding pharmacies," and separately says those pharmacies operate "under Section 503A of the Federal Food, Drug, and Cosmetic Act," with medication "independently tested by a third-party laboratory before it reaches you." No specific pharmacy is named — a real gap next to Precision Telemed's named Rush Pharmacy — and its human support is a "board-certified" clinician plus "Monthly provider check-ins" and a member community; the always-on layer the site markets hardest is "Aimee," its "AI health companion," not a person.
Strengths
States, in its own words, "Found partners exclusively with licensed 503A compounding pharmacies" — one of only two providers on this board making a sourced regulatory-category claim at all
Lowest headline price on this board ($99/mo, for its compounded-GLP-1 category), with its own FAQ stating the price stays flat as dose increases
Third-party lab testing of compounded medication is stated directly on its own product page, a step none of the other five providers we checked describe
Trade-offs
The $99/mo figure is stated for compounded GLP-1s as a category, not confirmed tirzepatide-specific — its dedicated tirzepatide page renders its actual price table as an interactive graphic our text-only check could not read
That price assumes a multi-month, cash-pay commitment: its own product page says pricing "reflects cash pay on a multi-month plan," and its FAQ says longer plans keep the monthly cost down without stating the month-to-month number
No specific pharmacy is named — the regulatory-category statement names no vendor, unlike Precision Telemed's named Rush Pharmacy
Visit Found ↗Shown for honest comparison · verified on the provider's own site in 2026
Everyone else we checked
5 more providers confirmed to sell compounded tirzepatide, each read live off its own site on 2026-08-02. Ordered by the same criteria as the row above: pharmacy disclosure first, then advertised price, low to high.
2
Precision Telemed
The only provider on this board that names its actual compounding pharmacy — Found also states a regulatory category, but only Precision Telemed names Rush Pharmacy specifically, on both its sermorelin and tirzepatide pages.
$199 the first month, then $249.99/mo ongoing. A $179.99/mo flat maintenance rate is available at the lowest (2mg) starting dose; most maintenance doses run at the higher figure.
A telehealth program built around a named compounding pharmacy: Precision Telemed's own product pages state medication is filled by "Rush Pharmacy, a licensed 503A compounding pharmacy," and describe the pharmacy as shipping nationwide with temperature-controlled cold-chain delivery. Every program bundles a physician telehealth consult with a free customized workout plan at no extra cost — the closest thing to structured coaching on this seed roster.
Strengths
Names its pharmacy (Rush Pharmacy) on both its sermorelin and tirzepatide pages — the only provider on this board that names an actual pharmacy, not just a category
States plainly, in its own FAQ, that it is available in all 50 states with no exclusions listed
A free customized workout plan is bundled into every program at no extra cost
Trade-offs
First-month price ($199) is lower than the ongoing rate ($249.99/mo) — budget for the higher number, not the sign-up price
The $179.99/mo flat rate applies only at the lowest (2mg) starting dose; most maintenance doses cost more
No dietitian or nurse is named specifically; support is physician-plus-workout-plan, not clinical nutrition or nursing
The lowest tirzepatide-specific starting price with a plainly stated dollar figure among the 6 providers we checked — though Found separately advertises an even lower $99/mo floor for its whole compounded-GLP-1 category, a number its own tirzepatide page does not confirm. CoreAge does not publish what a higher dose costs above its own floor either.
Advertised on CoreAge's own product page as "starting at $149 per month." No dose-tier price list or ceiling is published anywhere we could find on the live site.
CoreAge's tirzepatide page describes medication as "compounded in the USA" and prescriptions as overseen by "fully licensed and insured physicians," with every plan including "ongoing provider access," "24/7 Provider Support," and a patient community. Its own site names no compounding pharmacy and states no 503A/503B category — that facility-type question is simply not answered on the pages we could read.
Strengths
Lowest tirzepatide-specific starting price with a plainly stated dollar figure among the 6 providers we checked ($149/mo)
24/7 provider support and a patient community are included per its own product page
Every prescription is described as compounded in the USA and overseen by licensed physicians
Trade-offs
"Starting at" pricing — the site does not publish a ceiling or what a higher dose actually costs
No pharmacy is named and no 503A/503B category is disclosed anywhere on the live site
Full state coverage is not published; CoreAge's FAQ names only 4 states (California, Massachusetts, Rhode Island, Vermont) for physician-assignment purposes, which is not the same as a coverage list
Visit CoreAge Rx ↗Shown for honest comparison · verified on the provider's own site in 2026
4
yourEra
Tirzepatide only — yourEra does not sell sermorelin, and its most human-support-heavy tier is still marked "Coming soon."
Advertised on yourEra's single-page site as "Tirzepatide: from $169/mo." No dose-tier breakdown or ceiling is published.
yourEra runs its full product list — semaglutide, tirzepatide, NAD+, microdosing, and a not-yet-live "yourEra Optimum" tier — on one single-page site rather than separate product pages (a direct product-page URL we tried 404'd). Its homepage describes medications as "prepared and dispensed by state-licensed U.S. pharmacies" and shipped "free from licensed US pharmacies," with no pharmacy named and no 503A/503B category stated.
Strengths
A straightforward single-page pricing list — no separate signup flow to click through just to see the number
Medications are described as dispensed by state-licensed U.S. pharmacies, per its own homepage
Free shipping from its stated U.S. pharmacy network
Trade-offs
Sells tirzepatide only — no sermorelin option, so it does not appear on our sermorelin board
Its coaching/nutrition/at-home-labs tier ("yourEra Optimum") is marked "Coming soon" on the live site, not an active feature
No pharmacy is named and no 503A/503B category is disclosed; the site says only that "availability of specific treatments varies by state" with no published list
Visit yourEra ↗Shown for honest comparison · verified on the provider's own site in 2026
5
Henry Meds
The one provider on this board whose own pages disagree on which regulatory category applies to its compounding pharmacy — and, like most rows here, names no pharmacy at all.
HM
Henry's own FAQ and treatment pages state plainly, "The price of GLP-1 medication varies by treatment plan and dosing, but starts at $179/month" — a figure that covers its GLP-1 catalogue generally (including its compounded tirzepatide tablets) rather than a tirzepatide-specific number, and no dose-tier breakdown is published anywhere we could find.
Henry Meds sells compounded tirzepatide as an oral, dissolving tablet. Its own tirzepatide-tablets and GLP-1 treatment pages both describe medication as compounded "in a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility" — hedging between the two categories rather than naming one — while its Terms of Service state, in a separate and more definite sentence, that compounded medications "are prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act." No specific pharmacy is named on any page we checked. Support is "a licensed healthcare provider" plus "ongoing care"; no dietitian, nurse, or coaching program is named.
Strengths
States plainly, in its own words, that "these medications are customized, they're not FDA-approved in the same way as commercial drugs" — a direct disclosure, not left implied
No long-term contract by default: its own FAQ says "No long-term contracts! Henry offers convenient monthly plans" with the ability to "easily cancel any time"
One monthly payment is advertised as covering the provider visit, medication, supplies, and shipping together, per its own site
Trade-offs
Its own pages do not agree on which regulatory category applies: the tirzepatide-tablets page hedges "503(A)...or 503(B)," while its separate Terms of Service state "Section 503A" alone — and no specific pharmacy is named on either
"Starts at $179/month" is a floor for its GLP-1 catalogue generally, not a confirmed tirzepatide-specific figure, and no dose-tier breakdown is published
A customer who opts into an optional multi-month plan and then cancels early for a non-medical reason "may be required to pay out the rest of your balance," per its own FAQ — a real cost the default monthly plan does not carry
Visit Henry Meds ↗Shown for honest comparison · verified on the provider's own site in 2026
6
PlexusDx
The highest floor among the five providers here that publish an explicit "starting at" price — Found's $99 (for its GLP-1 category broadly), CoreAge's $149, yourEra's $169, and Henry Meds' $179 all undercut PlexusDx's $249 — and the only provider whose state-availability claim we could not confirm with a direct site visit.
PL
Advertised on PlexusDx's homepage as "Tirzepatide: Starts at $249/mo." No dose-tier breakdown was found — its deeper product pages returned HTTP 429 (rate-limited) on every attempt.
PlexusDx runs its own checkout/intake flow rather than functioning as a lead-gen or comparison page — its homepage states "independent clinicians review intake and write prescriptions" and medication ships from a "state-licensed compounding pharmacy," unnamed. It also states plainly, in its own words, that "compounded medications are not FDA-approved."
Strengths
Explicitly discloses that compounded medications are not FDA-approved, in its own words, rather than leaving it implied
Runs its own checkout/intake flow rather than functioning as a lead-gen or comparison site
States coverage in all 50 states, with its own stated caveat that availability can vary by state, provider licensure, and pharmacy licensure
Trade-offs
Highest of the five providers here that publish an explicit "starting at" price ($249/mo — above Found's $99 GLP-1-category floor, CoreAge's $149, yourEra's $169, and Henry Meds' $179)
Its all-50-states claim could not be confirmed by a direct site visit — PlexusDx's own product and blog pages returned HTTP 429 on every attempt, so this claim rests on a search-engine snippet of PlexusDx's own blog post, not a page we opened ourselves
No pharmacy is named and no 503A/503B category is disclosed
Visit PlexusDx ↗Shown for honest comparison · verified on the provider's own site in 2026
How this board is built
What determines a row's position is printed below, and nothing else moves it: a commercial relationship can earn a provider a disclosed, labelled placement, but it cannot change the criteria, the verified prices, or the drawbacks we print beside any row. The 4 factors below are what actually move a row up or down.
A floor isn't a price
3 of the 6 providers here quote a “starting at” number and never say what a real dose costs beyond it. Our top-ranked row is the outlier: it publishes two figures, not one — a lower rate that applies only at its smallest dose, and the higher rate everyone else on that plan actually pays — so we print both rather than repeating whichever number sounds best.
Pharmacy sourcing, on the record or not
We only mark a provider's pharmacy chip with a regulatory facility category when its own site names the facility AND states that category — of the 6 providers here, 2 do. Everyone else is marked "Not disclosed," and that's a real finding about the provider, not a gap in our research.
How the order is set
Rows are sorted by whether the provider clears the pharmacy-disclosure bar above, then by their own advertised price, low to high, for rows that tie. Any paid placement is marked Partner and printed as a disclosed commercial position — see the disclosure below the board.
One row we couldn't fully check ourselves
PlexusDx's own product pages returned HTTP 429 on every attempt on 2026-08-02, so its pricing comes from its homepage and its state-coverage claim comes from a search engine's snapshot of its own blog post — not a page we opened ourselves. Its row says so plainly rather than reading as confidently as the 3 rows we could verify firsthand.
Before you compare prices: every product on this board is compounded tirzepatide, made by a pharmacy under FDA compounding rules — not Zepbound, the FDA-approved brand. A compounded version can legally be sold only while the branded drug stays in shortage, and its formulation isn't independently reviewed the way an approved drug's is. What we score here is how honestly and clearly each provider states its price and sourcing — not whether tirzepatide, compounded or otherwise, is the right choice for you. Talk to a licensed clinician about that part.
Tested athletes: tirzepatide sits under WADA monitoring, not a ban
WADA does not list tirzepatide on its Prohibited List. Since 2026 it's on the Monitoring Program alongside semaglutide — data gets collected, but a legitimate prescription is not currently a rule violation. That status can change; confirm any compound against the official WADA Prohibited List before you rely on it.
Only tirzepatide sellers are ranked here. Shopping for a growth-hormone-axis peptide instead? Our sermorelin comparison uses the same pharmacy-first method against a different, smaller roster (yourEra doesn't sell sermorelin, so it's absent there).
Nothing on this page is medical advice. Compounded tirzepatide requires a clinician's prescription, is not an FDA-approved product in its own right, and its lawful sale depends on Zepbound (the approved brand) remaining in shortage under FDA compounding rules — that could change without notice. We read every price and sourcing claim on this page directly off each provider's own site on 2026-08-02; providers change prices without telling us, so verify the current number before you buy. Ask a licensed clinician whether a weight-management program of any kind fits your situation.
